Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study

NCT05527951 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2022-09-21

No results posted yet for this study

Summary

Measurement-based care (MBC) is an evidence-based practice that incorporates routine outcome assessment using validated rating scales to guide collaborative clinical decision-making. Although MBC results in improved outcomes for patients with major depressive disorder (MDD), there are barriers to its broad implementation in clinical settings. The use of "enhanced" MBC (eMBC), with mobile apps that allow patients to track outcomes and engage in self-management via WeChat, may address some of these barriers. The investigators hypothesize that implementation with eMBC using WeChat will be superior to standard MBC implementation using paper-pencil assessments at the clinic, for both implementation and clinical outcomes.

Conditions

Interventions

OTHER

eMBC

The experimental group will implement eMBC with our WeChat Easy to Recover from Depression Mini-Program, which consists of mood tracking and lay-coached self-management.

OTHER

standard MBC

The control intervention group will implement standard MBC using paper and pencil questionnaires.

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER
  • University of Toronto

    collaborator OTHER
  • University of Melbourne

    collaborator OTHER
  • Boston University

    collaborator OTHER
  • University of California

    collaborator OTHER
  • University of Alberta

    collaborator OTHER
  • Shanghai CDC for Mental Health

    collaborator UNKNOWN
  • Institute of Population Research, Peking University

    collaborator UNKNOWN
  • University of Michigan

    collaborator OTHER
  • Queen's University

    collaborator OTHER
  • Hongkou Mental Health Center

    collaborator UNKNOWN
  • Shanghai Mental Health Center

    lead OTHER

Principal Investigators

  • Jun Chen, M.D., Ph.D · Shanghai Mental Health Center(SMHC)

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-03
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05527951 on ClinicalTrials.gov